CUAMC
China Universal Asset Management Company’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Buy |
19,726
+232
| +1% | +$4.05K | 0.03% | 273 |
|
|
2025
Q1 | $245K | Sell |
19,494
-1,113
| -5% | -$14K | 0.02% | 293 |
|
|
2024
Q4 | $217K | Buy |
20,607
+1,962
| +11% | +$20.7K | 0.02% | 319 |
|
|
2024
Q3 | $270K | Buy |
18,645
+7,262
| +64% | +$105K | 0.03% | 276 |
|
|
2024
Q2 | $96.9K | Sell |
11,383
-7,070
| -38% | -$60.2K | 0.01% | 303 |
|
|
2024
Q1 | $189K | Buy |
18,453
+7,348
| +66% | +$75.1K | 0.02% | 297 |
|
|
2023
Q4 | $60.9K | Buy |
11,105
+8,652
| +353% | +$47.4K | 0.01% | 347 |
|
|
2023
Q3 | $9.27K | Buy |
2,453
+1,211
| +98% | +$4.58K | ﹤0.01% | 352 |
|
|
2023
Q2 | $8.32K | Sell |
1,242
-28
| -2% | -$188 | ﹤0.01% | 332 |
|
|
2023
Q1 | $8.27K | Buy |
1,270
+317
| +33% | +$2.06K | ﹤0.01% | 318 |
|
|
2022
Q4 | $8.13K | Buy |
953
+621
| +187% | +$5.3K | ﹤0.01% | 247 |
|
|
2022
Q3 | $2K | Buy |
+332
| New | +$2K | ﹤0.01% | 359 |
|